Filing Details
- Accession Number:
- 0001735276-21-000089
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-12 17:52:13
- Reporting Period:
- 2021-11-12
- Accepted Time:
- 2021-11-12 17:52:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1180432 | John Maraganore | 675 West Kendall Street Henri A. Termeer Square Cambridge MA 02142 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-11-12 | 33,978 | $7.10 | 248,743 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-11-12 | 10,365 | $170.36 | 238,378 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-11-12 | 7,742 | $171.35 | 230,636 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-11-12 | 14,518 | $172.22 | 216,118 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-11-12 | 683 | $173.25 | 215,435 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-11-12 | 670 | $174.34 | 214,765 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2021-11-12 | 33,978 | $0.00 | 33,978 | $7.10 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2021-11-30 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 3,133 | Indirect | by Managed Account |
Footnotes
- All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2020. The 33,978 options exercised and sold by the reporting person were due to expire on November 30, 2021.
- Sale prices ranged from $169.84 to $170.84.
- Sale prices ranged from $170.85 to $171.82.
- Sale prices ranged from $171.86 to $172.84.
- Sale prices ranged from $172.90 to $173.34.
- Sale prices ranged from $174.05 to $174.63.
- Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.